< Back to previous page
Organisation
Supporting clinical sciences
Department
Main organisation:Faculty of Medicine and Pharmacy
Lifecycle:6 Nov 2013 → Today
Organisation profile:
Supporting Clinical Sciences
Keywords:Clinical Science
Disciplines:Other biological sciences
Current researchers
41 - 50 of 170 results
- Johan De Mey (Member)
- Lynn De Mey (Member)
- Floris De Munck (Member)
- Tessa De Pauw (Member)
- Hendrik De Raeve (Member)
- Ewout De Roock (Member)
- Ruben De Rouck (Member)
- Phaedra De Schrijver (Member)
- Ann De Smedt (Member)
- Elke De Smedt (Member)
Projects
41 - 50 of 75
- Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.From1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- H2020: Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies.From1 Oct 2019 → TodayFunding: H2020 - European Institute of Innovation and Technology
- Visiting Polish researcher prof. Magdalena Rodak (22-28 september 2019)From22 Sep 2019 → 28 Sep 2019Funding: International Cooperation and Mobility
- Visiting Polish researcher prof. Marek Pruszynski (22 - 28 september 2019)From22 Sep 2019 → 28 Sep 2019Funding: International Cooperation and Mobility
- Innovatiemandaat Spin off: RIGLO : Redefining Neuromuscular MonitoringFrom1 Sep 2019 → 31 Aug 2021Funding: IWT / VLAIO - excluding impulse programmes
- SRP-Groeifinanciering: Single-domain antibody fragment (SdAb)-based TArgeted Radionuclide Therapy: STaRT programmeFrom1 Mar 2019 → TodayFunding: BOF - projects
- SRP-Onderzoekszwaartepunt: Societal Benefit of Markerless Stereotactic Body Radiotherapy: a Statistical Support based on Quantitative ImagingFrom1 Mar 2019 → 29 Feb 2024Funding: BOF - projects
- SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]From1 Mar 2019 → TodayFunding: BOF - projects
- Development of a NanoCAR-T cell approach for the treatment of multiple myelomaFrom1 Jan 2019 → 31 Dec 2023Funding: FWO fellowships
- Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 1520
- CD34 and SMA expression of superficial zone cells in the normal and pathological human meniscus
Authors: Heidi A Declercq, Ramses Forsyth, August Verbruggen, Rene Verdonk, Maria J Cornelissen, Peter C M Verdonk
Pages: 800-808 - Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors
Authors: Daniël Eefting, Yvonne M Schrage, Maartje J A Geirnaerdt, Saskia Le Cessie, Anthonie H M Taminiau, Judith V M G Bovée, Pancras Hogendoorn
Pages: 50-57 - The antagonist SPECT tracer 123I-iododexetimide binds preferentially to the muscarinic M1 receptor in-vivo, but is it also a potential tool to assess the occupancy of muscarinic M1 receptors by agonists ?
Authors: Jos Leon Eersels
- Arguments for an increasing differentiation towards fibrocartilaginous components in midportion Achilles tendinopathy
Authors: A Burssens, Ramses Forsyth, W Bongaerts, M Jagodzinski, N. Mahieu, Marleen Praet, Jan Victor
Pages: 1459-1467 - Epidemiology of primary bone tumors and economical aspects of bone metastasesEdition: 3rd
Authors: Ramses Forsyth
Pages: 17-23Number of pages: 7 - Analysis of Risk Factors for Patient Safety Events Occurring in the Emergency Department
Authors: Said Hachimi-Idrissi
Pages: E124-E135 - Triage: does it matter?
Authors: Said Hachimi-Idrissi
Pages: 1-5 - Chest compression release velocity: An independent determinant of end-tidal carbon dioxide in out-of-hospital cardiac arrest
Authors: Said Hachimi-Idrissi
Pages: 71-75 - The Therapeutic Potential of Anti-HER2 2Rs15d Nanobody Labeled with 225Ac – an In Vitro and In Vivo EvaluationEdition: 1Volume: 50
Authors: Marek Pruszyński, Matthias D'Huyvetter, Magdalena Rodak, Yana Dekempeneer, Tony Lahoutte, Edyta Cedrowska, Frank Bruchertseifer, Alfred Morgenstern
Pages: S7-S7Number of pages: 1 - Steroidogenesis-disrupting compounds can be effectively studied for major fertility-related endpoints using in-vitro cultured mouse follicles
Authors: Sandy Lenie
Pages: 143-152